CRDL
Cardiol Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.68 / 10
Netural
Fund flow analysis scores 7.31/10, indicating robust fund flow characteristics. Bullish trends in no significant trends contrast with bearish signals in overall, block, Small, Medium, Large, and Extra-large, suggesting positive liquidity momentum. Analyst coverage indicates overwhelmingly bullish analyst consensus with strong conviction. Rating distribution: Strong Buy(100.0%) among 1 analysts, supported by 4.06 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-01
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate50.0%
What is the market sentiment for CRDL?
- CRDL holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.68/10 (Netural).
